News
-
-
-
-
PRESS RELEASE
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
AB Science's AB8939 granted orphan drug designation by EMA in EU for treating acute myeloid leukemia, showing significant benefit over current therapies. Preclinical data reveals efficacy and safety -
PRESS RELEASE
La molécule AB8939 obtient la désignation de médicament orphelin auprès de l'EMA dans le traitement de la leucémie myéloïde aigue
La molécule AB8939 obtient la désignation de médicament orphelin dans l'Union Européenne pour le traitement de la leucémie myéloïde aigüe. AB Science fait un pas important dans le domaine de la recherche médicale -
-
-
REGULATED PRESS RELEASE
Derichebourg announces its financial calendar for 2024/2025 financial year
Derichebourg announces its financial calendar for 2024/2025 financial year. Events include half-year and full-year results, AGM dates. Derichebourg Group is a leader in metal recycling and environmental services -
-